A new report from Kalorama Information, a New York-based research firm, explores the economics of using rapid test diagnostic tools at the point of care.
The report also looks at the challenges at getting data from glucose monitors, urinalysis tests and other point of care diagnostic products into electronic medical records.
"Any manufacturers who want to make their POC products incredibly valuable should make sure they can link up with major EMR systems," says Shara Rosen, diagnostics analyst at Kalorama.
The report reviews various products and assesses their markets with forecasts to 2013, forecasts the market for over-the-counter self-testing devices, and examines the role of EMRs and possible effects of health care reform. The report includes profiles of more than 100 companies competing in the market.
The 300-page report, "Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads," is available for $3,995 at kaloramainformation.com.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access